Hormone replacement therapy [topp]
Weight Loss [fndg]
Obese [dsyn]
Menopausal [phsf]
Women [popg]
Objective [inpr]
Onset [qlco]
Menopause [phsf]
Weight Gain [fndg]
Certain [qlco]
cardiovascular risk factor [dsyn]
Frequently [tmco]
Observed [ftcn]
Study [mnob]
metabolic effects [phsf]
Combined [qlco]
Hormone replacement therapy [topp]
17 beta-Estradiol [horm, phsu, strd]
mU/g [qnco]
days [tmco]
Oral [spco]
medroxyprogesterone acetate 5 MG [clnd]
Calorimetry, Indirect [lbpr]
Methods [inpr]
Patients [podg]
Nine [qnco]
Study [mnob]
Twice [inpr]
3 Months [tmco]
Oral [spco]
Glucose [bacs, carb, phsu]
Load [idcn]
75 g [qnco]
Total body [ffas]
weight [orga]
Unaltered [qlco]
3 Months [tmco]
Control Group [grup]
Loss [qnco]
KG [geoa]
Decrease [qlco]
Waist-Hip Ratio [orga]
Observed [ftcn]
Group [idcn]
Group [idcn]
lipid oxidation [moft]
Observed [ftcn]
mg/kg/min [qnco]
mg/kg/min [qnco]
Substitution [idcn]
P NOS [aapp, imft]
Total energy expenditure [fndg]
Thermogenesis [orgf]
Increased [qnco]
Glucose [bacs, carb, phsu]
Lipid [lipd]
protein oxidation [moft]
Stable [qlco]
months [tmco]
Control Group [grup]
Insulin [aapp, horm, phsu]
Response [orga]
Oral [spco]
Glucose [bacs, carb, phsu]
Load [idcn]
Diminished [qnco]
Hormone replacement therapy [topp]
mU/L [qnco]
mU/L [qnco]
Cholesterol, LDL [bacs, strd]
Improved [qlco]
Hormone replacement therapy [topp]
Plasma [bdsu]
Triglycerides [bacs, lipd]
Altered [ftcn]
Conclusions [idcn]
Combined [qlco]
Hormone replacement therapy [topp]
PREVENT [phsu]
Weight Gain [fndg]
FAVOR [orch, phsu, vita]
Weight Loss [fndg]
Increasing [ftcn]
lipid oxidation [moft]
3 Months [tmco]
treatment [ftcn]
Insulin [aapp, horm, phsu]
Response [orga]
Plasma lipids [lbpr]
Energy Expenditure [phsf]
Science [ocdi]
Ireland [geoa]
LTD [ortf]
Reserve [acty]
